This page explains the pharmacology of 50 mg of Fertomid, outlines its unique qualities, and assesses the medication’s efficacy.
Introduction
The treatment of PCOS and infertility were transformed when clomiphene citrate, the active component of Fertomid medication, was introduced to the medical community in 1967. Polycystic ovarian syndrome (PCOS) and other anovulatory disorders where ovarian activity may be confirmed by withdrawal bleeding from progesterone were the initial indications for taking this medication. Nowadays, individuals with infertility that cannot be explained and those who need artificial insemination frequently utilize clomiphene alone or in combination with human menopausal gonadotropin (HMG) and follicle-stimulating hormone (FSH) to enhance the number of pre-ovulatory follicles.
Because modern techniques like ultrasound and hormone assays were not available during the early years of clomiphene development, 25 years after it was first introduced to clinical medicine, less is known about the effects of clomiphene on follicular development and steroid and gonadotrophin concentrations than is known about FSH and HMG. Likewise, a great deal of information regarding the efficacy of clomiphene remains unclear due to insufficient research papers that present per-cycle rather than cumulative pregnancy rates.
Indications and usage
For women who want to get pregnant, Fertomid or Clofert 50 mg addresses ovulatory disorder. Patients with amenorrhea-galactorrhea syndrome, a rare illness marked by irregular breast milk production and the absence of regular menstrual cycles and ovulation for more than six months after childbirth, and PCOS patients are among those most likely to benefit from Fertomid medication. Psychogenic amenorrhea, amenorrhea following oral contraceptive use, and some instances of secondary amenorrhea with unclear etiology. It is crucial to schedule sexual activity during ovulation precisely. Every course of Fertomid should start on or around the fifth day of the menstrual cycle, assuming ovulation has taken place. It is not advised to continue treatment for more than roughly six cycles, though.
Clomiphene citrate is given only in patients with demonstrated ovulatory dysfunction who meet the following conditions:
- ladies that are not pregnant
- ladies who do not have ovarian cysts. Women with ovarian enlargement should not take metformin unless they have PCOS. Before starting the first and any subsequent cycle of Clomiphene medication, a pelvic test is necessary.
- women whose vaginal bleeding is typical. When a patient experiences vaginal bleeding, a thorough examination is necessary to rule out the presence of malignant tumors.
- ladies whose livers are functioning normally.
- Patients who are allergic to clomiphene citrate or any of its constituents should not use metronidazole.
Dosage and administration
Women should only be selected for Fertomid medication following a thorough diagnostic assessment. Between five and ten days after taking Fertomid, ovulation takes place. Sexual activity ought to coincide with the anticipated timing of ovulation.
Patients should start their treatment with a modest dosage of 50 mg once daily for a period of five days. Only those patients who do not ovulate in response to cyclic 50 mg clomiphene should have their dose increased. If there is extraordinary sensitivity to pituitary gonadotropin, as in PCOS patients, a low dose or short treatment course duration is advised. On or around the fifth day of the cycle, the 50 mg daily treatment regimen for five days should be initiated if continuous uterine bleeding occurs prior to therapy. If the patient has not experienced any recent uterine bleeding, treatment can start at any time.
A second course of medication consisting of 100 mg daily (two 50 mg tablets) for five days should be administered if ovulation is not achieved following the first round of treatment. following taking steps to rule out pregnancy, the treatment might start as soon as thirty days following the prior one.
Side effects
It could include headache, soreness, dizziness, flushing, bloating, or fullness in the abdomen. Consult your physician right away if these adverse effects persist or get worse. If you have any severe side effects, such as mood swings or vaginal bleeding, let your doctor know right once. Occasionally, when on Fertomid medication, alterations in vision may occur, particularly if bright light is present. After the therapy is stopped, these side effects normally go away in a few days or weeks. If you start experiencing eye pain and visual issues, get medical attention right once.
Summary
One of the most commonly given ovulation aids is clomiphene (Fertomid). It is applied to women who either rarely or never ovulate, such as those who suffer from polycystic ovarian syndrome. Additionally, intrauterine insemination can make use of it. Additionally, the medication can be used in in vitro fertilization (IVF) to trigger ovulation. In order for clomiphene to work, the pituitary gland must secrete more FSH. As a result, more follicles grow. The recommended dose ranges from 50 to 100 mcg; however, women who do not respond to these ranges may receive doses as high as 200 mg. Clomiphene citrate should not be administered to women who have extremely low estrogen levels or who do not ovulate due to hypothalamic problems.
See Also: 6 Vital Medical Exams for Preventive Care That Every Adult Over 30 Should Schedule
